AUG 13, 2018 10:30 AM PDT

A Kind of Forensics to ID the Source of Bacterial Outbreaks

WRITTEN BY: Carmen Leitch

Scientists at Mayo Clinic have developed a way to use whole genome sequencing to locate the source of deadly bacterial pathogens. Some strains of Staphylococcus aureus have become resistant to antibiotics, and this common microbe has become a killer. Now, forensic-style science can help stop the spread of this bug.

Scanning electromicrograph of Staphylococcus aureus bacteria. Credit: NIAID

“If we have two or more people infected with the same type of bacterium, the question sometimes arises as to whether they got the organisms from one another or a shared source. The answer to this question can shape an approach to limit further spread,” explained Robin Patel, M.D., a clinical microbiologist with Mayo Clinic Department of Laboratory Medicine and Pathology. “Or, a patient might have a bacterial infection and later a second infection with the same type of bacterium. Whole genome sequencing can determine whether the patient picked up a new ‘version’ of the bacterium or if the old one never went away. This can matter for management of that patient.”

S. aureus, also known as staph bacteria, are a common cause of infections on the skin and in underlying tissue, like boils and abscesses. These infections usually aren’t serious. However, the bacterium can also cause a life-threatening infection that can get into bones, joints and the bloodstream.

Finding out where the infection is coming from can be difficult without using whole genome sequencing on the pathogen. 

“It is important to develop tests that can distinguish how individual bacteria are related to one another and to understand and control the spread of bacterial infections,” noted Nicholas Chia, Ph.D., assistant director of the Center for Individualized Medicine Microbiome Program.

The researchers at Mayo are trying to bring the bench closer to the bedside; they want to use testing methods that encompass the whole bacterial genome when assessing pathogens.

“With microbial whole-genome sequencing, we can discover all there is to possibly know about an organism. It is cutting-edge technology that’s a little like CSI (crime scene investigation) in a way. We are providing information to assess relatedness, which will, in turn, direct interventions to interrupt transmission,” explained Dr. Patel.

It’s been established that sequencing the whole genome can help in identifying the source of dangerous pathogens, like methicillin-resistant Staphylococcus aureus, or MRSA. Outbreaks of that superbug have occurred in sports teams at all playing levels as well as healthcare facilities. Limiting the number of infected individuals can depend on finding its source.

Related: Cleansers, Antibiotics may Contribute to the Growth of MRSA in the Home

“Examining the entire bacterial genome, we will, in the near future, be able to identify resistance genes and mutations, therefore defining which antibiotics are going to be active. Our early research indicates that we can use whole genome sequencing to inform drug selection and therefore how that patient should be treated. It is so new, we’ve elected to look at this application separately from the strain relatedness testing approach we are currently performing,” noted Dr. Patel.

Not many US medical centers use whole-genome sequencing to characterize Staph bacteria when it’s found in the clinic like Mayo does. Researchers are hopeful that this testing will expand, and they’ve made the tests available.

Learn more about typical approaches to dealing with bacterial outbreaks.

Source: Mayo Clinic

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
FEB 02, 2020
FEB 02, 2020
These cosmetics damage breast cells' DNA
A new approach to studying the effects of two common chemicals used in cosmetics and sunscreens found they can cause DNA damage in breast cells at surprisi
FEB 05, 2020
Clinical & Molecular DX
FEB 05, 2020
A new CRISPR-based test for coronavirus infections
A surge in infections has caused panic surrounding the coronavirus (2019-nCoV) outbreak to reach a fever pitch. Despite being only moderately infective, 20
FEB 17, 2020
Genetics & Genomics
FEB 17, 2020
Engineering a Genome
Scientists are learning more about how to use the genetic code to make a synthetic genome with specific biological functions.
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood.
MAR 27, 2020
Genetics & Genomics
MAR 27, 2020
Expanding the Genomic Regions That Can Be Targeted With CRISPR
CRISPR gene-editing technology has sparked a revolution in biomedical research and is poised to have far-reaching applications in medicine.
MAR 31, 2020
Cannabis Sciences
MAR 31, 2020
Scientists Are Mapping the Cannabis Genome
A remarkable amount of the cannabis genome is either missing from the map or has yet to be mapped at all. Researchers from the University of Saskatchewan a
Loading Comments...